Role of Raltegravir in HIV-1 Management

Kristina EE Rokas, P Brandon Bookstaver, Caitlin L Shamroe, S Scott Sutton, Vanessa E Millisor, Jacquelyn E Bryant, Sharon B Weissman

Open source

DOI
10.1345/aph.1q616
Published
2012-04
Container
Annals of Pharmacotherapy
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1345/aph.1q616,
  title = {Role of Raltegravir in HIV-1 Management},
  author = {Kristina EE Rokas and P Brandon Bookstaver and Caitlin L Shamroe and S Scott Sutton and Vanessa E Millisor and Jacquelyn E Bryant and Sharon B Weissman},
  year = {2012},
  journal = {Annals of Pharmacotherapy},
  doi = {10.1345/aph.1q616},
  url = {https://doi.org/10.1345/aph.1q616}
}

RIS

TY  - JOUR
TI  - Role of Raltegravir in HIV-1 Management
AU  - Kristina EE Rokas
AU  - P Brandon Bookstaver
AU  - Caitlin L Shamroe
AU  - S Scott Sutton
AU  - Vanessa E Millisor
AU  - Jacquelyn E Bryant
AU  - Sharon B Weissman
PY  - 2012
JO  - Annals of Pharmacotherapy
DO  - 10.1345/aph.1q616
UR  - https://doi.org/10.1345/aph.1q616
ER  - 

APA

Rokas, K. E., Bookstaver, P. B., Shamroe, C. L., Sutton, S. S., Millisor, V. E., Bryant, J. E., & Weissman, S. B. (2012). Role of Raltegravir in HIV-1 Management. Annals of Pharmacotherapy. https://doi.org/10.1345/aph.1q616

Source records